← Back to Vaccine Database

ADXS11-001

Live attenuated vaccine · VDDBV0068

Target & Classification

HPVHuman papillomavirus
Live attenuated vaccine
Cervical Cancer; Cancer; Head and Neck Cancer; Carcinoma, Non-Small-Cell Lung; HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Human Papillomavirus-Related Anal Squamous Cell Carcinoma; Human Papillomavirus-Related Cervical Squamous Cell Carcinoma; Squamous Cell Carcinoma of Head and Neck
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials5

NCT IDPhaseDisease / Condition
NCT02164461 Phase 2Cervical Cancer; Cancer; Head and Neck Cancer
NCT01598792 Phase 1Carcinoma, Non-Small-Cell Lung
NCT02002182 Phase 2HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
NCT02291055 Phase 2Human Papillomavirus-Related Anal Squamous Cell Carcinoma; Human Papillomavirus-Related Cervical Squamous Cell Carcinoma
NCT02531854 Phase 2Squamous Cell Carcinoma of Head and Neck